Abivax S.A.
(ABVX - NASDAQ)
114,79 USD
📋 Profilo Aziendale

Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases.

|